Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis

In China, hepatocellular carcinoma (HCC) usually develops following a long history of chronic hepatitis B infection or cirrhosis. To evaluate the diagnostic role of annexin A2 (ANXA2), a possible tumor marker, in patients with hepatitis B virus (HBV)-related HCC, particularly those with a history of...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, ZHIKUN, LING, QI, WANG, JIANGUO, XIE, HAIYANG, XU, XIAO, ZHENG, SHUSEN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742823/
https://www.ncbi.nlm.nih.gov/pubmed/23946789
http://dx.doi.org/10.3892/ol.2013.1337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742823/
https://www.ncbi.nlm.nih.gov/pubmed/23946789
http://dx.doi.org/10.3892/ol.2013.1337

Ejemplares similares